18F-FAPI PET in Cancers of Unknown Primary Site
ConditionCancer of Unknown Primary Site
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-85
SponsorFirst Affiliated Hospital of Zhejiang University
About this trial
This study aims to evaluate the diagnostic efficacy, therapeutic assessment, prognostic analysis, and impact on clinical treatment decisions of 18F-FAPI PET/CT in patients with cancer of unknown primary.
Eligibility criteria
Qualifiers
Patients with clinical or imaging suspicion of cancer of unknown primary origin.
Patients with 18F FAPI PET scans.
Disqualifiers
Concurrent presence of other active malignant tumors or a history of other malignant tumors within the past 5 years;
Severe uncontrollable diseases or active infections;
Ineligible participants for project informed consent.
Pregnant and lactating women.
Trial design
Treatments tested in this trial
- 18F-FAPI PET
Treatment groups
120 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov